March 14, 2018
A six-month pilot program conducted by Sharp Rees-Stealy Medical Group in San Diego found that diabetes patients using Glooko’s care management platform were more engaged with their care and achieved better control of their blood glucose levels, according to a case study released by the company.
From April to October 2016, Sharp Rees-Stealy care teams provided access to Glooko's platform to 50...
February 14, 2018
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.
The MIDS module allows clinicians to create a customized treatment plan and send it to Type 2 diabetes patients directly through the company’...
July 19, 2017
Oscar Health is working with Humana to offer commercial health insurance to small businesses in a nine-county Nashville, Tenn. area. Tech-saavy insurance startup Oscar is teaming up with incumbent Humana at a time when it’s just begun to expand from the individual market into working with employers through its Oscar for Business unit. Humana will provide licenses to operate in Nashville as well...
July 17, 2017
Novo Nordisk and Glooko are working together to help people manage diabetes from their phones. The companies have partnered on the Cornerstones4Care Powered by Glooko, an app melding Novo Nordisk’s knowledge of diabetes and personalized patient support with Glooko’s digital platform and data analytics know-how.
The idea behind the app is to provide, for people with diabetes, a means of measuring...
June 27, 2017
Diabetes data management company Glooko has raised $35 million in new funding. The company already had strategic investments from Samsung and Medtronic; in this new round the Mayo Clinic and insulin pump maker Insulet join those ranks. Toronto-based Georgian Partners led the round, with participation from existing investors Canaan Partners and Social Capital, in addition to the aforementioned...
June 9, 2017
Diabetes management is a focus area for a number of digital health companies, and increasingly large medical device companies like Medtronic and Dexcom are turning to smartphone apps and connected devices for their consumer offerings. So it’s no surprise that at the 77th Scientific Sessions of the American Diabetes Association, which start today, there is a significant health tech presence.
June 1, 2017
Digital diabetes management company Glooko and device maker Dexcom have expanded their partnership, effectively creating on-demand access to continuous glucose monitor data for both physicians and patients who use the two companies’ products.
Glooko and Dexcom began working together in June 2015, when Glooko first began integrating CGMs and insulin pumps into its platform. But for the past two...
April 27, 2017
New York-based Fit4D, which offers digital coaching for people with diabetes, is partnering with global diabetes data management company Glooko to bring a more data-driven approach to their mobile patient engagement tools. The pairing will give Fit4D’s coaches access to Glooko’s device-agnostic platform, which people with diabetes see in the form of a mobile app they can use to automatically sync...
February 8, 2017
The remote patient monitoring market saw a big jump in the last year, with 7.1 million patients in 2016 enrolled in some form of digital health program featuring connected medical devices as a core part of their care plan, according to new data.
Swedish market research firm Berg Insight, which specializes in IoT verticals, tracked a 44 percent jump in remotely monitored patients last year. While...
January 31, 2017
Glooko, a Mountain View, California-based remote monitoring platform for diabetes, has partnered with Ascensia, a business unit created last year when Panasonic Healthcare Holdings acquired Bayer Diabetes Care. Ascensia makes the Contour Next One and Contour Next Link, a pair of connected glucometers that received FDA clearance last year. Another device, Contour Plus One, is not yet FDA-cleared...